相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autoencoder Based Feature Selection Method for Classification of Anticancer Drug Response
Xiaolu Xu et al.
FRONTIERS IN GENETICS (2019)
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Marien Pascual et al.
BLOOD (2019)
p53/miR-30a-5p/SOX4 feedback loop mediates cellular proliferation, apoptosis, and migration of non-small-cell lung cancer
Xiaowei Quan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling
Yize Zhang et al.
CANCER CELL INTERNATIONAL (2019)
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
Alexander Thiem et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Gallic Acid Triggers Iron-Dependent Cell Death with Apoptotic, Ferroptotic, and Necroptotic Features
Ho Man Tang et al.
TOXINS (2019)
PD-L1 Distribution and Perspective for Cancer Immunotherapy-Blockade, Knockdown, or Inhibition
Yilun Wu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Inflammation and Oxidative Stress in an Obese State and the Protective Effects of Gallic Acid
Phiwayinkosi V. Dludla et al.
NUTRIENTS (2019)
p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value
Angela Santoro et al.
CELL REPORTS (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
Antimicrobial activity of gallic acid against food-related Pseudomonas strains and its use as biocontrol tool to improve the shelf life of fresh black truffles
Elena Sorrentino et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2018)
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Giovanni Blandino et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Gallic acid inhibits bladder cancer cell proliferation and migration via regulating fatty acid synthase (FAS)
Chung-Chia Liao et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2018)
Gallic Acid Content and an Antioxidant Mechanism Are Responsible for the Antiproliferative Activity of 'Ataulfo' Mango Peel on LS180 Cells
Gustavo. R. Velderrain-Rodriguez et al.
MOLECULES (2018)
Nobiletin Inhibits CD36-Dependent Tumor Angiogenesis, Migration, Invasion, and Sphere Formation Through the Cd36/Stat3/Nf-Kb Signaling Axis
Nipin Sp et al.
NUTRIENTS (2018)
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
Xiaoxiao Wang et al.
NEOPLASIA (2018)
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
Lu Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b/p53 axis
Flavia Biamonte et al.
CELL DEATH & DISEASE (2018)
The intracellular signalosome of PD-L1 in cancer cells
David Escors et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER+ Breast Cancer Cells
Nipin Sp et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action
Thazin Nwe Aung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
A Trp53 fl/fl Pten fl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging
Marisa R. Buchakjian et al.
PLOS ONE (2017)
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
Kirstine Jacobsen et al.
NATURE COMMUNICATIONS (2017)
Lung Cancer: Understanding its Molecular Pathology and the 2015 WHO Classification
Kentaro Inamura
FRONTIERS IN ONCOLOGY (2017)
Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer
Meng Li et al.
BRITISH JOURNAL OF CANCER (2017)
A systematic analysis of FDA-approved anticancer drugs
Jingchun Sun et al.
BMC SYSTEMS BIOLOGY (2017)
Regulation of PD-L1: a novel role of pro-survival signalling in cancer
J. Chen et al.
ANNALS OF ONCOLOGY (2016)
Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells
Dong Young Kang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status
Yoon Jin Cha et al.
LUNG CANCER (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Gallic acid induced apoptotic events in HCT-15 colon cancer cells
Aruna Priyadharshni Subramanian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
Vincenzo Sforza et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Antiviral Effects of Black Raspberry (Rubus coreanus) Seed and Its Gallic Acid against Influenza Virus Infection
Ji-Hye Lee et al.
VIRUSES-BASEL (2016)
Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth
Sourav Bhattacharya et al.
ONCOTARGET (2016)
Melatonin as a potential anticarcinogen for non-small-cell lung cancer
Zhiqiang Ma et al.
ONCOTARGET (2016)
Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer
Ai N. H. Phan et al.
ONCOTARGET (2016)
AKT-STAT3 Pathway as a Downstream Target of EGFR Signaling to Regulate PD-L1 Expression on NSCLC cells
Sherif Abdelhamed et al.
JOURNAL OF CANCER (2016)
Activation of endoplasmic reticulum stress is involved in the activity of icariin against human lung adenocarcinoma cells
Shouyin Di et al.
APOPTOSIS (2015)
The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts
Nipin Sp et al.
BMC CANCER (2015)
Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
Abhisek Swaika et al.
MOLECULAR IMMUNOLOGY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Overcoming T cell exhaustion in infection and cancer
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2015)
MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma
Wei Guo et al.
TUMOR BIOLOGY (2015)
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
Chunxiao Xu et al.
CANCER CELL (2014)
Receptor Tyrosine Kinases: Legacy of the First Two Decades
Joseph Schlessinger
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Non-Small Cell Lung Cancer, Version 2.2013 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)
Management of non-small-cell lung cancer: recent developments
Martin Reck et al.
LANCET (2013)
The Human TLR Innate Immune Gene Family Is Differentially Influenced by DNA Stress and p53 Status in Cancer Cells
Maria Shatz et al.
CANCER RESEARCH (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2
Sonja Textor et al.
CANCER RESEARCH (2011)
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
Lukas Baitsch et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The Toll-Like Receptor Gene Family Is Integrated into Human DNA Damage and p53 Networks
Daniel Menendez et al.
PLOS GENETICS (2011)
Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis
Bo Ra You et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN-γ-Induced B7-H1 Expression in Cholangiocytes
Ai-Yu Gong et al.
JOURNAL OF IMMUNOLOGY (2009)
Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice
Komal Raina et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A superoxide anion generator, pyrogallol, inhibits the growth of HeLa cells via cell cycle arrest and apoptosis
Sang Wook Kim et al.
MOLECULAR CARCINOGENESIS (2008)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Study of antimutagenic and antioxidant activities of Gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia lentiscus -: Confirmation by microarray expression profiling
Afef Abdelwahed et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors
Charles Erlichman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials
DW Bell et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
T Winton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Interferons α and γ induce p53-dependent and p53-independent apoptosis, respectively
C Porta et al.
ONCOGENE (2005)
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
T Le Chevalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: its effect on cell proliferation and implication for therapy
L Zheng et al.
CELL RESEARCH (2004)
Classification of anticancer drugs -: a new system based on therapeutic targets
E Espinosa et al.
CANCER TREATMENT REVIEWS (2003)
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
A Takaoka et al.
NATURE (2003)
Akt enhances Mdm2-mediated ubiquitination and degradation of p53
Y Ogawara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The new World Health Organization classification of lung tumours
E Brambilla et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans
S Shahrzad et al.
JOURNAL OF NUTRITION (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
